pyrroles has been researched along with Ependymoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billups, CA; Blaney, SM; Boyett, JM; Daryani, VM; Gajjar, A; Goldsmith, KC; Leary, S; Stewart, CF; Tanos, R; Wetmore, C | 1 |
1 trial(s) available for pyrroles and Ependymoma
Article | Year |
---|---|
Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Child; Child, Preschool; Combined Modality Therapy; Drug Monitoring; Drug Resistance, Neoplasm; Ependymoma; Female; Glioma; Humans; Indoles; Male; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Protein Kinase Inhibitors; Pyrroles; Retreatment; Sunitinib; Treatment Outcome; Young Adult | 2016 |